Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NCAPD2P1 is a pseudogene, specifically the non-SMC condensin I complex subunit D2 pseudogene 1[1][3][4]. As a pseudogene, it represents a non-functional copy of a gene that has accumulated mutations over evolutionary time. However, recent research has challenged the traditional view of pseudogenes as merely "junk" DNA, revealing that some pseudogenes can have regulatory functions[5]. Pseudogenes can be transcribed into RNA and may regulate their protein-coding counterparts through various mechanisms, including acting as microRNA decoys, competing for regulatory factors, or being processed into small interfering RNAs[5]. While pseudogenes are often deregulated during cancer progression, suggesting potential functional roles in disease, NCAPD2P1 itself is not considered a direct therapeutic target since it lacks protein-coding capacity[5]. The parent gene would be related to the condensin I complex, which is involved in chromosome condensation and segregation during cell division, but as a pseudogene, NCAPD2P1 does not encode a functional protein product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on non-SMC condensin I complex subunit D2 pseudogene 1 (NCAPD2P1).